Status:

COMPLETED

Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL)

Lead Sponsor:

Abbott Medical Optics

Conditions:

Cataract

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of a new investigational modified light transmission monofocal intraocular lens compared to a conventional intraocular lens (IOL).

Detailed Description

The investigational IOL will be found to be safe and effective with respect to visual acuity, color vision, contrast sensitivity and complications and will be similar to results for the ZA9003 control...

Eligibility Criteria

Inclusion

  • Age 18 years of age or older
  • Bilateral cataracts for which phacoemulsification extraction and posterior IOL implantation has been planned
  • Visual potential in both eyes of 20/30 Snellen or better after cataract removal and IOL implantation
  • Preoperative corneal astigmatism of 1.5 diopters or less

Exclusion

  • Use of systemic or ocular medications that may affect vision
  • Uncontrolled systemic or recurrent ocular disease
  • Requiring an intraocular lens \<15.0 or \>26.0 diopters
  • Abnormal results with the Farnsworth-Munsell D-15 and/or Ishihara color plates
  • History of ocular trauma or prior ocular surgery
  • Known pathology that may affect visual acuity or visual field
  • Corneal abnormalities
  • Pupil abnormalities
  • Capsule or zonular abnormalities

Key Trial Info

Start Date :

December 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2009

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT00747227

Start Date

December 1 2006

End Date

June 1 2009

Last Update

November 11 2011

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Patrick Aiello, M.D.

Scottsdale, Arizona, United States, 85054

2

Randall E. Cole, M.D.

Rogers, Arkansas, United States, 72756

3

Aron Rose, M.D.

New Haven, Connecticut, United States, 06510

4

Y. Ralph Chu, M.D.

Bloomington, Minnesota, United States, 55420

Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) | DecenTrialz